SCHEMBL1441

SCHEMBL1441

C[C]=CC(=O)OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1440 1.00
SCHEMBL1439 1.00
SCHEMBL7672001 0.82 HCAR2 (0.50)
SCHEMBL27203936 0.81
SCHEMBL4667392 0.80
SCHEMBL3867193 0.79 HCAR2 (0.43)
SCHEMBL3867194 0.79 HCAR2 (0.43)
SCHEMBL1932544 0.78
SCHEMBL7660667 0.78
SCHEMBL11274494 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0439096-B1 Improvements in or relating to beta lactam production BIOCHEMIE GMBH (AT) 2003-12-17 EP claimed
US-20240132675-A1 POLYMER HAVING METAL-OXYGEN-METAL BOND AS PRIMARY CHAIN, COMPOSITION THEREOF, SOLID MATERIAL AND PRODUCTION METHOD THEREOF, AND ELECTRONIC COMPONENT AND FIBER TORAY INDUSTRIES, INC. (JP) 2024-04-25 US disclosed
US-20210221981-A1 RUBBER COMPOSITION, TIRE AND PREPARATION METHOD OF RUBBER COMPOSITION SUMITOMO RUBBER INDUSTRIES, LTD. (JP) 2021-07-22 US disclosed
US-8507673-B2 Process for preparing 5,7 diaminopyrazolo [1,5-A] pyrimidine compounds EMORY UNIVERSITY (US) 2013-08-13 US disclosed
US-20120041198-A1 Process for Preparing 5,7 Diaminopyrazolo [1,5-a] Pyrimidine Compounds EMORY UNIVERSITY 2012-02-16 US disclosed
US-8034810-B2 Matrix metalloproteinase inhibitors; antiinflammatory agengs; rheumatoid arthritis, osteoarthritis; antitumor, anticarcinogenic, and antimetastasis agents; respiratory system disorders, chronic obstructive pulmonary disease, deblocking, deprotecting NOVARTIS AG (CH) 2011-10-11 US disclosed
WO-2010068838-A2 PROCESSES FOR PREPARING 5,7 DIAMINOPYRAZOLO[1,5-α] PYRIMIDINE COMPOUNDS EMORY UNIVERSITY (US) 2010-06-17 WO disclosed
EP-1202961-B1 ARYLSULFONAMIDO-SUBSTITUTED HYDROXAMIC ACID DERIVATIVES NOVARTIS AG (CH) 2010-01-20 EP disclosed
EP-2085379-A1 Arylsulfonamido-substituted hydroxamic acid derivatives Novartis AG (CH) 2009-08-05 EP disclosed
US-20080275127-A1 Arylsulfonamido-substituted hydroxamic acid derivatives BREITENSTEIN WERNER 2008-11-06 US disclosed
US-4595677-A Substituted tetrapeptides CIBA-GEIGY CORPORATION (US) 1986-06-17 US disclosed
EP-0174912-A2 Phosphorus compounds, process for their preparations and their use CIBA-GEIGY AG (CH) 1986-03-19 EP disclosed
EP-0169812-A1 Phosphatidyl compounds, process for their preparation and their use CIBA-GEIGY AG (CH) 1986-01-29 EP disclosed
EP-0163286-A2 Acylated sugars, method for their preparation and their use CIBA-GEIGY AG (CH) 1985-12-04 EP disclosed
US-4464366-A Cephem compounds having a terminal aminocarboxylic acid grouping and containing an azacyclyl(thio)ureido group CIBA GEIGY CORPORATION (US) 1984-08-07 US disclosed
US-4448776-A Method of using certain substituted aliphatic secondary amines or their salts for easing breathing BUCHER KARL (CH) 1984-05-15 US disclosed
US-4406889-A IMMUNOLOGY, PEPTIDES CIBA-GEIGY CORPORATION (US) 1983-09-27 US disclosed
US-4232151-A ANTIBIOTICS SHIONOGI & CO., LTD. (JP) 1980-11-04 US disclosed
US-4223132-A Selective conversion of benzyl alcohol carboxylates to the free acid form SHIONOGI & CO., LTD. (JP) 1980-09-16 US disclosed
US-3989685-A FROM PENICILLIN-1-OXIDE SHINOGI & CO., LTD. (JA) 1976-11-02 US disclosed